NR1H4 and metabolic dysfunction-associated steatohepatitis: Genetically engineered farnesoid X receptor (FXR) knockout mice [34,35] and melanocortin 4 receptor (Mc4r) knockout mice [36], and models in which NASH and liver tumors are induced in mice by drugs such as streptozotocin [37], have been also documented.